They are candidates for clinical trials. They are the antimalarial drug amodiaquine, the anti-psychotic zuclopenthixol, and the blood pressure medication nebivolol.
University of New Mexico researcher Oprea and his team published in ACS Pharmacology & Translational Science, reported that an older antimalarial drug called amodiaquine was effective in eradicating the virus in test tube experiments.
They look through a library of approved drugs and found something like Remdesivir but is also much cheaper.
The anti-psychotic zuclophentixol and a blood pressure medication called nebivolol also cleared the virus in the experiments.
Having more COVID drugs gives doctors more options for drug treatment cocktails.